Confluence Investment Management Cut By $1.09 Million Its Thermo Fisher Scientific (TMO) Holding; Goldcorp Inc. (GG) Covered By 10 Bullish Analysts Last Week

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Confluence Investment Management Llc decreased Thermo Fisher Scientific Inc. (TMO) stake by 3.05% reported in 2017Q4 SEC filing. Confluence Investment Management Llc sold 5,792 shares as Thermo Fisher Scientific Inc. (TMO)’s stock rose 8.51%. The Confluence Investment Management Llc holds 183,968 shares with $34.93 million value, down from 189,760 last quarter. Thermo Fisher Scientific Inc. now has $85.71 billion valuation. The stock increased 0.25% or $0.54 during the last trading session, reaching $213.33. About 748,683 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 33.66% since April 13, 2017 and is uptrending. It has outperformed by 22.11% the S&P500.

Among 21 analysts covering Goldcorp Inc. (NYSE:GG), 10 have Buy rating, 0 Sell and 11 Hold. Therefore 48% are positive. Goldcorp Inc. had 61 analyst reports since July 24, 2015 according to SRatingsIntel. JP Morgan maintained it with “Overweight” rating and $18 target in Wednesday, November 15 report. National Bank Canada downgraded the stock to “Sector Perform” rating in Monday, July 24 report. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. The stock of Goldcorp Inc. (NYSE:GG) earned “Neutral” rating by Goldman Sachs on Wednesday, May 11. The stock of Goldcorp Inc. (NYSE:GG) has “Outperform” rating given on Thursday, September 8 by National Bank Canada. The firm has “Hold” rating given on Monday, October 3 by Deutsche Bank. TD Securities upgraded the shares of GG in report on Wednesday, January 17 to “Buy” rating. Macquarie Research downgraded the stock to “Neutral” rating in Tuesday, March 15 report. The rating was maintained by Jefferies on Friday, July 14 with “Hold”. The stock has “Outperform” rating by Scotia Capital on Friday, April 28. See Goldcorp Inc. (NYSE:GG) latest ratings:

17/01/2018 Broker: TD Securities Rating: Buy New Target: $22.0 Upgrade
17/01/2018 Broker: Canaccord Genuity Rating: Hold Downgrade
16/01/2018 Broker: Jefferies Rating: Hold New Target: $15.5 Maintain
16/01/2018 Broker: Scotia Capital Rating: Buy New Target: $17.5 Maintain
15/01/2018 Broker: Credit Suisse Rating: Buy New Target: $19.0 Upgrade
03/12/2017 Broker: RBC Capital Markets Rating: Buy New Target: $17.0 Maintain
30/11/2017 Broker: Citigroup Old Rating: Neutral New Rating: Buy Upgrade
22/11/2017 Broker: HSBC Old Rating: Buy New Rating: Hold Downgrade
15/11/2017 Broker: JP Morgan Rating: Overweight Old Target: $16 New Target: $18 Maintain
01/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $18.0 Upgrade

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific has $250 highest and $140 lowest target. $207.21’s average target is -2.87% below currents $213.33 stock price. Thermo Fisher Scientific had 61 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies maintained it with “Hold” rating and $205.0 target in Friday, October 20 report. The rating was maintained by Leerink Swann on Friday, April 28 with “Buy”. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, March 30. Jefferies has “Hold” rating and $160 target. The firm earned “Hold” rating on Tuesday, June 6 by Jefferies. Morgan Stanley maintained it with “Overweight” rating and $227 target in Thursday, February 1 report. The company was maintained on Tuesday, July 19 by Barclays Capital. Bank of America maintained the stock with “Buy” rating in Thursday, February 1 report. Leerink Swann maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, February 1. Leerink Swann has “Buy” rating and $239.0 target. As per Wednesday, January 3, the company rating was initiated by Evercore. The firm earned “Buy” rating on Thursday, July 20 by Cleveland.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on April, 25. They expect $2.40 EPS, up 15.38% or $0.32 from last year’s $2.08 per share. TMO’s profit will be $964.29 million for 22.22 P/E if the $2.40 EPS becomes a reality. After $2.79 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -13.98% negative EPS growth.

Since December 15, 2017, it had 0 buys, and 8 sales for $37.14 million activity. Shares for $9.59M were sold by CASPER MARC N on Friday, December 15. The insider Williamson Stephen sold 5,000 shares worth $1.05 million. Parrett William G sold $209,796 worth of stock. Herrema Gregory J. had sold 33,327 shares worth $7.32M on Friday, February 2. Durbin Patrick M sold $1.31M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, February 5.

Confluence Investment Management Llc increased Ishares Corporate Ex Financial stake by 13,994 shares to 391,747 valued at $9.61 million in 2017Q4. It also upped Ares Capital Corp. (NASDAQ:ARCC) stake by 102,683 shares and now owns 5.14M shares. Energy Select Sector (XLE) was raised too.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.05, from 0.96 in 2017Q3. It turned negative, as 43 investors sold TMO shares while 410 reduced holdings. 93 funds opened positions while 319 raised stakes. 335.65 million shares or 0.74% more from 333.20 million shares in 2017Q3 were reported. Wesbanco Bancorp holds 0.32% or 24,789 shares. Metropolitan Life Insurance Communications Ny has invested 0.18% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Moreover, Research & Management Company has 0.18% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2,990 shares. Bb&T Corporation has invested 0.01% in Thermo Fisher Scientific Inc. (NYSE:TMO). Parallax Volatility Advisers LP has invested 0% in Thermo Fisher Scientific Inc. (NYSE:TMO). Denver Investment Advsr Lc accumulated 1,416 shares. Ameriprise Fincl Inc has 0.13% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Natixis Asset owns 160,648 shares. 5,616 are held by Drw Secs Limited Liability Company. At Bancorporation holds 0.41% or 20,301 shares in its portfolio. Capital City Tru Fl holds 16,764 shares. Victory Mgmt has 19,923 shares. Bristol John W & New York reported 360,989 shares stake. Peak Asset Limited Co holds 0.27% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 3,898 shares. The Connecticut-based Hartford Investment Communication has invested 0.3% in Thermo Fisher Scientific Inc. (NYSE:TMO).

Goldcorp Inc. acquires, explores for, develops, and operates precious metal properties in Canada, the United States, Mexico, and Central and South America. The company has market cap of $12.04 billion. It primarily explores for gold, silver, lead, zinc, and copper deposits. It has a 18.75 P/E ratio. The company’s principal producing mining properties include the Red Lake, Porcupine, Musselwhite, and Éléonore mines in Canada; the Peñasquito mine in Mexico; the Cerro Negro mine in Argentina; and the Pueblo Viejo mine in the Dominican Republic.

The stock decreased 0.56% or $0.08 during the last trading session, reaching $14.25. About 5.51 million shares traded. Goldcorp Inc. (NYSE:GG) has declined 14.21% since April 13, 2017 and is downtrending. It has underperformed by 25.76% the S&P500.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: